The latest industry intelligence research on the Asthma Spacers market offers a repository
of valuable data on the size, share, and growth rate of the Asthma Spacers market for the forecast
period, 2020 - 2027. Importantly, examination of various facets of the industry
including but not limited to production volume, product sales, demand and
supply assessment and forecast for the period, 2020 - 2027 aim at offering
business owners a competitive edge over their rivals. The study further
conducts a qualitative evaluation of various driving forces expected to shape
the future of the industry during the estimated period. The global Asthma Spacers Market is forecasted to be worth USD 2.38 Billion by 2027,
according to a current analysis by Emergen Research.
Key Highlights From The
Report
In September 2018,
Allergan plc acquired Bonti, Inc. The addition of Bonti is a strategic
investment in its medical aesthetics company's growth and has the opportunity
to boost its best-in-class medicinal aesthetics portfolio.
Over the forecast
period, the Aerochamber segment is forecasted to hold the largest market with a
CAGR of 3.6%. It is easier to use for persons who have a hard time handling the
hand to mouth method. There are fewer side effects with the use of an
aero-chamber since less medication is processed in the back of the mouth.
Compared to retail
and hospital pharmacies, the growing amount of internet users and the
accessibility of asthma spacers online at a lower cost, which is expected to
stimulate the growth of the e-commerce sector rapidly.
Over the forecast
timeline, the clinics & hospital segment is anticipated to dominate the
market as asthma leads to 439,000 hospitalizations and 1.3 million annual
emergency visits.
The region of North
America is anticipated to hold the largest market over the forecast period. The
factor that has resulted in market growth is the increasing asthma incidence
and raising awareness of the use of asthma spacers in the region.
Key participants
include Lupin Limited, Trudell Medical Group Ltd., GlaxoSmithKline plc, Cipla
Limited, Merck & Co., Inc, Clement Clarke International Ltd, PARI GmbH,
AstraZeneca plc/AB, Fisons plc, and Allergan plc among others.
Request
for sample report@ https://www.emergenresearch.com/request-sample/307
Type Outlook (Revenue, USD Billion; 2017-2027)
Inspirease
Optichamber
Aerochamber
Volumatic
Distribution Channel Outlook (Revenue, USD
Billion; 2017-2027)
E-commerce
Retail
Pharmacy
Hospital
Pharmacy
End-Use Outlook (Revenue, USD Billion;
2017-2027)
Homecare
Clinics
& Hospitals
Others
Regional Outlook (Revenue, USD Billion;
2017-2027)
North America
Europe
Asia Pacific
Latin America
MEA
No comments:
Post a Comment